Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
Aaron Wealth Advisors LLC Has $1.08 Million Stock Holdings in 10x Genomics $TXG
03:38am, Wednesday, 08'th Apr 2026
Aaron Wealth Advisors LLC raised its holdings in 10x Genomics (NASDAQ: TXG) by 68.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Th
10x Genomics (NASDAQ:TXG) Shares Gap Up on Analyst Upgrade
01:30am, Wednesday, 01'st Apr 2026
Shares of 10x Genomics (NASDAQ: TXG - Get Free Report) gapped up prior to trading on Tuesday after William Blair upgraded the stock from a market perform rating to an outperform rating. The stock had
10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout
02:10pm, Tuesday, 31'st Mar 2026
• 10x Genomics shares are powering higher. What's fueling TXG momentum?
10x Genomics (NASDAQ:TXG) Given Consensus Recommendation of “Hold” by Brokerages
02:29am, Thursday, 26'th Mar 2026
10x Genomics (NASDAQ: TXG - Get Free Report) has earned a consensus recommendation of "Hold" from the sixteen ratings firms that are currently covering the company, MarketBeat reports. Three research
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
10:52am, Wednesday, 25'th Mar 2026
Cathie Wood added to her stakes in Circle Internet Group, Arcturus Therapeutics, and 10x Genomics on Tuesday. Circle tumbled on Tuesday following reports that regulatory tightening may be on the way f
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world to
10x Genomics: Undervalued Amid Consumables-Led Transition
01:35am, Tuesday, 24'th Mar 2026
10x Genomics is undervalued, with a BUY rating and 18% upside to a $20.47 target, driven by robust consumables growth. Consumables, comprising 83% of revenue, continue double-digit growth, offsetting
These Are the Only 3 Stocks That Cathie Wood Bought Last Week
07:07am, Monday, 23'rd Mar 2026
Cathie Wood added to her stakes in Figma, Arcturus Therapeutics, and 10x Genomics last week. Analysts see Figma's growth slowing dramatically in the next two years, but an 83% drop from last year's hi
Reviewing Hims & Hers Health (NYSE:HIMS) & 10x Genomics (NASDAQ:TXG)
02:56am, Monday, 23'rd Mar 2026
10x Genomics (NASDAQ: TXG - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two compa
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
08:00am, Tuesday, 17'th Mar 2026
- Fueled by best-in-class technology and deep expertise in genome engineering and AI, PerturbAI is uniquely positioned to redefine therapeutic discovery, making it more scalable, translatable and cost
Stock Market Today, March 16: Nasdaq Gains 1% Stocks on Easing Oil Prices and AI Optimism
05:49pm, Monday, 16'th Mar 2026
On March 16, 2026, cooling oil prices meant markets erased some of last week's losses today, though geopolitical risks lingered.
Torex Gold Resources (TSE:TXG) Share Price Passes Above 200 Day Moving Average – Here’s Why
02:57am, Wednesday, 11'th Mar 2026
Shares of Torex Gold Resources Inc. (TSE: TXG - Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of C$63.34 and traded as hig
Head to Head Survey: MSP Recovery (NASDAQ:MSPR) and 10x Genomics (NASDAQ:TXG)
04:02am, Saturday, 07'th Mar 2026
10x Genomics (NASDAQ: TXG - Get Free Report) and MSP Recovery (NASDAQ: MSPR - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based
Financial Review: 10x Genomics (NASDAQ:TXG) & Decision Diagnostics (OTCMKTS:DECN)
02:32am, Friday, 20'th Feb 2026
Decision Diagnostics (OTCMKTS:DECN - Get Free Report) and 10x Genomics (NASDAQ: TXG - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two busines
Financial Survey: 10x Genomics (NASDAQ:TXG) and Biotricity (OTCMKTS:BTCY)
02:32am, Friday, 20'th Feb 2026
Biotricity (OTCMKTS:BTCY - Get Free Report) and 10x Genomics (NASDAQ: TXG - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the s
